Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK will no longer seek approval for dutasteride (Avodart) to prevent prostate cancer
GSK will no longer seek approval for dutasteride (Avodart) to prevent prostate cancer
GSK will no longer seek approval for dutasteride (Avodart) to prevent prostate cancer
Submitted by
admin
on March 24, 2011 - 4:46pm
Source:
LA Times, CA
News Tags:
prostate cancer
Avodart
GSK
Headline:
GSK will no longer seek approval for dutasteride (Avodart) to prevent prostate cancer
Do Not Allow Advertisers to Use My Personal information
